Published in Ned Tijdschr Geneeskd on November 11, 2006
S-100B concentrations predict disease-free survival in stage III melanoma patients. Ann Surg Oncol (2009) 0.90
Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surg (2009) 0.88
Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients. Dermatol Res Pract (2009) 0.85
[Cancer registries and the quality of oncological care]. Ned Tijdschr Geneeskd (2006) 0.75
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax (2004) 2.77
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 2.06
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
[Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987]. Ned Tijdschr Geneeskd (2002) 1.94
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int (2003) 1.90
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer (2004) 1.85
Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst (2010) 1.78
Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol (2008) 1.69
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer (2002) 1.66
Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol (2005) 1.66
Epidemiology of neuroendocrine tumours. Neuroendocrinology (2004) 1.59
Gender differences in stage-adjusted bladder cancer survival. Urology (2000) 1.55
[Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002]. Ned Tijdschr Geneeskd (2005) 1.50
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
[The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001]. Ned Tijdschr Geneeskd (2005) 1.44
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg (2005) 1.44
[A comparative study of the expenditures on health research in 7 western countries in 1997 places the Netherlands at the bottom of the list]. Ned Tijdschr Geneeskd (2002) 1.39
Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer (2006) 1.38
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol (2012) 1.34
Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol (2001) 1.33
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg (2003) 1.31
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer (2008) 1.29
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer (2004) 1.29
European health systems and cancer care. Ann Oncol (2003) 1.27
Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol (2007) 1.24
Improving outcome for patients with pancreatic cancer through centralization. Br J Surg (2011) 1.19
Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol (2005) 1.19
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
[The risk of cancer in the Netherlands]. Ned Tijdschr Geneeskd (2008) 1.16
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer (2010) 1.15
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol (2010) 1.15
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol (2005) 1.14
Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol (2007) 1.14
Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer (1995) 1.12
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol (2003) 1.10
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer (2005) 1.08
The Stellenbosch University Medical Library slide classification, storage, retrieval, and issue system. Bull Med Libr Assoc (1977) 1.08
Screening for second primary melanomas: is it efficient? Br J Dermatol (2013) 1.07
Does sunlight prevent cancer? A systematic review. Eur J Cancer (2006) 1.07
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (2010) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg (2012) 1.04
Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant (2011) 1.04
Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia (2012) 1.03
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur Radiol (2012) 1.03
Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer (2010) 1.03
The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv (2013) 1.03
The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02
Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer (2010) 1.01
Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat (2005) 1.00
Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer (2006) 0.99
Comment on 'psychological distress in patients with cancer: is screening the effective solution?'. Br J Cancer (2013) 0.98
[Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe]. Ned Tijdschr Geneeskd (2006) 0.98
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer (2003) 0.97
Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol (2007) 0.96
Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer (2004) 0.95
Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer (2005) 0.94
Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol (2011) 0.94
Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction. Eur J Cancer (2010) 0.94
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol (2013) 0.93
Behaviour partly explains educational differences in cancer incidence in the south-eastern Netherlands: the longitudinal GLOBE study. Eur J Cancer Prev (2004) 0.92
Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity. Eur J Cancer (2006) 0.91
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype. Curr Cancer Drug Targets (2008) 0.91
Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003. Br J Cancer (2007) 0.90
Testicular cancer: trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970. Eur J Cancer (2007) 0.89
Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev (2004) 0.89
Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol (2011) 0.88
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol (2011) 0.88
Variation in management of early breast cancer in the Netherlands, 2003-2006. Eur J Surg Oncol (2010) 0.88
COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer (2007) 0.87
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003. Acta Oncol (2006) 0.87
Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. Eur J Gastroenterol Hepatol (2004) 0.87
Space-time clustering patterns of gliomas in The Netherlands suggest an infectious aetiology. Eur J Cancer (2005) 0.87
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer (2003) 0.87
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Ann Oncol (2006) 0.87
Enteropathy-associated T-cell lymphoma: improving treatment strategies. Dig Dis (2015) 0.86
Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study. Breast Cancer Res Treat (2007) 0.86
Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008. Eur J Cancer (2011) 0.86
IGF-1 CA repeat variant and breast cancer risk in postmenopausal women. Eur J Cancer (2007) 0.86